Table 2 Laboratory findings in patients with myositis-associated ILD
Variables | N | Median | IQR |
|---|---|---|---|
Laboratory data | |||
CK (IU/L) | 55 | 150 | (66–393) |
Aldolase (IU/L) | 53 | 7.4 | (5.1–19.0) |
AST (IU/L) | 55 | 34 | (23–59) |
ALT (IU/L) | 55 | 28 | (20–46) |
LDH (IU/L) | 55 | 302 | (239–391) |
PaO2 (torr) | 44 | 79.4 | (69.6–90.2) |
KL-6 (U/mL) | 53 | 1030 | (440–1793) |
SP-D (ng/mL) | 49 | 204 | (95–204) |
SP-A (ng/mL) | 37 | 72.7 | (55.4–105.1) |
Pulmonary function test | |||
%VC (%) | 40 | 83.6 | (67.3–94.7) |
FEV1/FEV (%) | 40 | 83.7 | (78.8–92.8) |
%DLco (%) | 40 | 54.8 | (39.0–72.0) |
BALF cell findings | |||
TCC (× 105/mL) | 45 | 3.5 | (2.8–5.8) |
Macrophages (%) | 45 | 45.7 | (34.4–63.9) |
Lymphocytes (%) | 45 | 33.4 | (17.4–47.5) |
Neutrophils (%) | 45 | 7.8 | (2.2–15.4) |
Eosinophils (%) | 45 | 2.2 | (0.9–7.2) |
CD4/CD8 | 43 | 0.4 | (0.2–1.1) |